Impact of Pre‐Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents

Authors:

Abstract
Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.
Funding Information
  • Ministero della Salute
  • European Commission

This publication has 8 references indexed in Scilit: